TABLE 2.
Body, liver, and epididymal fat weight and serum biochemistry values in ob/ob mice receiving placebo, DHA, or resolvin E1
| Parameter | Placebo | DHA | Resolvin E1 |
|---|---|---|---|
| Body weight (g) | 38.8 ± 1.4 | 39.6 ± 1.2 | 35.1 ± 0.7 |
| Liver weight (g) | 2.64 ± 0.13 | 2.39 ± 0.25 | 2.32 ± 0.17 |
| Liver/body weight ratio (%) | 6.80 ± 0.18 | 5.98 ± 0.45 | 6.57 ± 0.40 |
| Epididymal fat weight (g) | 2.70 ± 0.21 | 3.09 ± 0.14 | 2.23 ± 0.08 |
| Epididymal fat/body weight ratio (%) | 6.88 ± 0.34 | 7.81 ± 0.40 | 6.34 ± 0.21 |
| Serum cholesterol (mg/dl) | 117.3 ± 5.2 | 106.0 ± 9.1 | 126.0 ± 6.2 |
| Serum TAG (mg/dl) | 44.4 ± 4.9 | 49.6 ± 8.6 | 33.3 ± 1.3 |
| Serum ALT (U/L) | 343.0 ± 40.9 | 236.0 ± 65.4 | 186.7 ± 11.3* |
| Serum FFA (μM) | 2044.0 ± 142.4 | 1914.0 ± 125.1 | 1798.0 ± 130.4 |
Data are expressed as means ± se; n = 10, n = 5, or n = 5 for placebo, DHA, and resolvin E1, respectively.
*
P < 0.05 vs. placebo group.